K063186 is an FDA 510(k) clearance for the ATHENA MULTI-LYTE RUBELLA IGG TEST SYSTEM. This device is classified as a Enzyme Linked Immunoabsorbent Assay, Rubella (Class II - Special Controls, product code LFX).
Submitted by Zeus Scientific, Inc. (Raritan, US). The FDA issued a Cleared decision on March 21, 2007, 152 days after receiving the submission on October 20, 2006.
This device falls under the Microbiology FDA review panel. Regulated under 21 CFR 866.3510.
| 510(k) Number | K063186 FDA.gov |
| FDA Decision | Cleared Substantially Equivalent - Traditional 510(k) (SESE) |
| Date Received | October 20, 2006 |
| Decision Date | March 21, 2007 |
| Days to Decision | 152 days |
| Submission Type | Traditional |
| Review Panel | Microbiology (MI) |
| Summary | Statement |
| Product Code | LFX — Enzyme Linked Immunoabsorbent Assay, Rubella |
| Device Class | Class II - Special Controls |
| CFR Regulation | 21 CFR 866.3510 |